8G2M
The tumor activated anti-CTLA-4 monoclonal antibody XTX101 demonstrates tumor-growth inhibition and tumor-selective pharmacodynamics in mouse models of cancer
External Resource: Annotation
SAbDab Antibody Annotation SAbDab Database Homepage
Chain | Chain Class | Chain Subclass | Chain Type | Antigen Name(s) | Provenance Source |
---|---|---|---|---|---|
B [auth H] | Heavy Chain | IGHV1 | - | masking peptide | SAbDab (2024-09-13) |
C [auth L] | Light Chain | IGKV6 | Kappa | masking peptide | SAbDab (2024-09-13) |
Thera-SAbDab Antibody Annotation Thera-SAbDab Database Homepage
Chain | Name | Target | Provenance Source |
---|---|---|---|
B [auth H] | Vilastobart | CTLA4/CD152 | Therapeutic SAbDab (2024-09-13) |
C [auth L] | Vilastobart | CTLA4/CD152 | Therapeutic SAbDab (2024-09-13) |